Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies by Hoperia, Victoria et al.
Hindawi Publishing Corporation
International Journal of Pediatric Endocrinology
Volume 2010, Article ID 690108, 5 pages
doi:10.1155/2010/690108
Clinical Study
ThyroidFineNeedleAspiration Biopsiesin Children:Study of
Cytological-Histological Correlation andImmunostainingwith
Thyroid Peroxidase Monoclonal Antibodies
Victoria Hoperia,1 Alexander Larin,1 Kirk Jensen,2 Andrew Bauer,2 andVasily Vasko2
1Center for Endocrine Surgery, Kharkivske Shose 121, 02091 Kyiv, Ukraine
2Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
Correspondence should be addressed to Vasily Vasko, vvasko@usuhs.mil
Received 28 December 2009; Revised 19 February 2010; Accepted 30 April 2010
Academic Editor: Gary L. Francis
Copyright © 2010 Victoria Hoperia et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Context. There is limited data comparing results of ﬁne needle aspiration biopsies (FNABs) to histological diagnosis in children.
Design. FNABs were performed in 707 children and cytological results were compared to histology in 165 cases. The usefulness
of immunostaining with anti-TPO monoclonal antibodies (MoAb47) on FNAB samples was examined in 54 operated patients.
Results. Among unsatisfactory, benign, suspicious, and malignant FNAB, the histological diagnoses were benign in 12/12 (100%),
69/70 (98.5%), 40/50 (80.0%), and 0/33 (0%), respectively. After surgery, malignancy was established in 44/165 (26.6%) cases. The
sensitivity, speciﬁcity, and positive and negative predictive values were 95.4%, 55.8%, 61.7%, and 95% with standard FNAB; and
100%, 75%, 73.3, and 100% withMoAb47. AmongsuspiciousFNAB, positiveMoAb47stainingwas areliable marker forexclusion
of malignancy. Conclusion. Benign and malignant FNAB accurately predict histological diagnosis. In suspicious FNAB, MoAb47
immunostaining may be a useful adjunct to standard cytology.
1.Introduction
The prevalence of thyroid nodules in adults is well
established through large population-based studies, with a
r e p o r t e dr a n g eo f3 . 2 %t o8 %[ 1]. In children, thyroid
nodules are less frequently detected than in adults and
sources quote a prevalence of 1.5% [2]. However, the rate of
malignancy in operated pediatric thyroid nodules is higher
than in adults, varying from 9.2% to 50% [3–7]. As a
consequence, there is increased anxiety for malignancy in
childhood thyroid nodules and a more aggressive treatment
approach has been suggested for any nodule discovered in
childhood.
Fine-needle aspiration biopsy (FNAB) is currently
considered the most eﬀective technique for morphological
diagnosis of thyroid nodules. Traditionally, FNAB results are
divided into four categories: inadequate or nondiagnostic,
benign, indeterminate (otherwise described as suspicious
for neoplasm), and malignant [8]. High diagnostic accuracy
of FNAB was reported in cases of benign and malignant
cytology. However, the suspicious FNABs are problematic
with 10% to 60% of these lesions proven to be malignant
after histological examination. In recent recommendation of
Papanicolaou Society of Cytopathology, suspicious FNABs
were subcategorized into three groups: indeterminate,
follicular neoplasms, and suspect of carcinoma [9]. In a
large study including 4703 FNABs, the rates of malignancy
in operated indeterminate, follicular neoplasms, and suspect
of carcinoma FNAB were 13.5%, 32.2%, and 64.7%,
respectively [10].
A number of new techniques have been investigated
in order to improve the accuracy of FNAB. These tech-
niques attempt to take advantages of diﬀerences in genetic,
molecular, and biochemical signatures between benign
and malignant thyroid lesions to identify reliable malig-
nancy markers. Some markers, such as thyroid peroxidase,
dipeptidyl-aminopeptidase IV (DPPIV), and Hector Batti-
fora mesothelial antigen-1 (HBMA-1) were shown to be
strongly correlated with thyroid cancer progression and are
considered as candidate for cytological practice [11, 12]2 International Journal of Pediatric Endocrinology
Thyroid peroxidase (TPO) is an integral thyroid enzyme
that is imperative for normal thyroid function and is
considered as one of the major diﬀerentiated gene products
of thyroid follicular cells. TPO immunodetection with
monoclonal antibodies (MoAb47) in thyroid tissue showed
positive immunoreactivity in normal thyroid cells and
cells from thyroid adenomas but negative immunostaining
was found in the majority of carcinoma [13]. In FNAB
samples,MoAb47immunostainingimprovedtheaccuracyof
standard FNAB, especially in diagnosis of follicular thyroid
lesions [14, 15].
The potential importance of malignancy markers in
the diagnosis of pediatric thyroid nodules was suggested
by previous studies [5]. Taking into consideration that
pediatric thyroid cancer is prone to rapid progression, the
consequence of false-negative FNAB is of great concern. On
the other hand, aggressive therapeutic approach based on
false-positive FNAB can result in unnecessary surgery.
The present study was undertaken to review the diag-
nostic accuracy of traditional cytology in a large cohort of
pediatric patients and to determine the utility of MoAb47
immunostaining for diagnoses of pediatric thyroid nodules.
2.MaterialandMethods
2.1. Patients. T h ep r o t o c o lf o rt h i ss t u d yw a sa p p r o v e d
by the ethical and clinical research committee of Center
for Endocrine Surgery Kiev, Ukraine. From January 1999
through December 2008, thyroidal FNABs were performed
at Department of Cytology, Center for Endocrine Surgery
Kiev, Ukraine in 17,809 patients including 707 (0.4%)
children with ages ranged from 6 to 17 years old. Forty
six patients that underwent FNAB (6.5%) were born before
1986, implicating possible irradiation after the Chernobyl
accident.
2.2. Fine Needle Aspiration Biopsies. FNABs were done with
or without ultrasound guidance. Thyroid nodules that
were easily palpable were aspirated by a board-certiﬁed
cytopathologist and nonpalpable thyroid nodules were aspi-
rated under ultrasound guidance by a radiologist.
All aspirations were performed with 23- to 25-gauge
needles attached to a 10- or 20-mL syringe with or without a
syringeholder.Air-dried smearswereimmediately examined
by a cytologist for the presence of epithelial cells and samples
were considered as adequate if it contained 8 to 10 clusters
of at least 6 to 8 well-preserved and well-visualized follicular
cells. After ﬁxation in methanol, aspirates were stained using
Giemsa method.
The results of FNAB were classiﬁed as (1) unsatisfac-
tory (impossible to perform cytological interpretation), (2)
benign (nonneoplastic and autoimmune thyroiditis), (3)
suspicious (cellular adenomatoid nodule, “follicular lesions”
andcaseswithatypicalcytology),and(4)malignant(thyroid
carcinoma or other malignancy).
2.3. Immunostaining. Immunocytochemistry with MoAb 47
was performed on air-dried FNA samples within 24 hours
after biopsy. After neutralization of endogenous peroxidase
in a phosphate-buﬀered saline (PBS) solution containing
0.1% hydrogen peroxide for 5 minutes, slides were incubated
overnight at 4◦C with anti-TPO monoclonal antibody
(MoAb 47 clone; Dako, Glostrup, Denmark). Immunostain-
ing was performed with the Vectastain Universal Quik kit
(Vector Lab, Burlingame CA) according to the manufac-
turer’s instructions.
The percentage of positive cells was evaluated as pre-
viously described [12]. The reaction with MoAb47 was
considered as positive when more than 80% of epithelial
cells demonstrated dark-brown granular staining of the
cytoplasm with a halo around the nuclei. Cells exhibiting an
abnormal staining pattern, which include low intensity with
no perinuclear ring, were not considered as positive. Positive
c o n t r o l sw e r ep e r f o r m e do ns m e a r sf r o mo p e r a t e db e n i g n
nodules. Negative controls were performed by omitting the
primary antibody.
2.4. Pathology. One hundred sixty-ﬁve children were surgi-
cally treated in the Department of Surgery and thyroid tissue
samples were available for comparison of cytological exami-
nation with histological analysis. Histological diagnoses were
established according to the WHO classiﬁcation of thyroid
tumors and included 121 benign and 44 malignant thyroid
lesions.
2.5. Statistical Analysis. SPSS software (version 13.0, 2004
SPSS Inc., Chicago, IL, USA) was used for statistical analysis.
The sensitivity (Se), speciﬁcity (Sp), positive predictive
values (PPVs), and negative (NPV) were calculated as
following: Se = true positive/(true positive + false negative);
Sp = true negative/(true negative + false positive); PPV =
true positive/(true positive + false positive); and NPV = true
negative/(true negative + false negative).
3. Results
3.1. Demographic Data and Distribution of Cytological Diag-
n o s e si nC h i l d r e nw i t hT h y r o i dN o d u l e s . In total, 707 FNAB
from 559 female and 148 male patients (female/male 3.7:1)
were examined. The age of patients ranged from 5 to 17
years. There were 52 prepubertal patients (age 5–10 years)
including 33 female and 19 male (female/male 1.7:1); and
655 pubertal patients (age 11–17 years) including 526 female
and 129 male (female/male 4.0:1). The number of patients
that underwent thyroid FNAB in function of their age is
presented in Table 1, showing a distinct rise during puberty
and a disproportionate increase in females.
The total distributions of initial cytological diagnoses in
the four diagnostic categories were as follows: 66 unsatisfac-
tory (9.3%), 510 benign (72.1%), 86 suspicious (12.2%), and
45 malignant (6.4%). The cytological diagnoses, classiﬁed by
ages and gender groups are shown in Table 2.
3.2. Comparison of Cytological and Histological Diagnoses.
One hundred sixty-ﬁve patients with preoperative FNAB
underwent partial or total thyroidectomy based on clinicalInternational Journal of Pediatric Endocrinology 3
Table 1: Number of pediatric patients that underwent thyroid
FNAB.
Age Number of patients
Female Male Total
42 1 3
50 1 1
60 4 4
73 3 6
84 0 4
97 4 1 1
10 17 6 23
11 16 7 23
12 20 11 31
13 42 9 51
14 74 20 94
15 126 27 153
16 139 24 163
17 109 31 140
Total 559 148 707
Table 2: Cytological diagnoses in prepubertal and pubertal chil-
dren.
Age Cytology
Non adequate
(66)
Benign
(510)
Suspicious
(86)
Malignant
(45)
Gender
prepubertal
Female (33) 4 22 2 5
Male (19) 3 8 6 2
Pubertal
Female (526) 43 385 67 31
Male (129) 16 95 11 7
data and FNAB results. Most of patients with benign FNAB
were referred to surgery because of large nodule size (average
34.4mm). The average nodule size in patients with a benign
FNAB was signiﬁcantly higher compared to patients with
suspicious FNAB (23.0mm) or malignant FNAB (27.2mm).
On histology there were 121 benign and 44 malignant
diagnoses. The distribution of cytological diagnoses in
function of histology is shown in Table 3.
In patients with unsatisfactory FNAB, histological exam-
ination frequently reveals the presence of cysts. In patients
with benign FNAB, 69/70 (98.5%) were diagnosed as benign
on histology. The most frequent diagnoses were multin-
odular goiter (MNG) and follicular adenomas (FA). The
discrepancy between cytological and histological diagnoses
in this category was in a solitary case in which a follicular
variant of papillary thyroid cancer (FVPTC) was misdiag-
nosed as a benign thyroid lesion. In patients with suspicious
FNAB, the ﬁnal histological analysis revealed malignancy in
10/50 (20%). Tumors with uncertain malignant potential
such as adenomas with limited nuclear features of papillary
cancer (AA) were diagnosed in 8/50 (16%). In 32/50 (64%)
Table 3: Distribution of cytological diagnoses in function of
histology.
Histology Cytology
Non adequate
(12)
Benign
(70)
Suspicious
(50)
Malignant
(33)
Benign (121)
Cyst 8 0 0 0
MNG 0 23 8 0
FA 4 42 21 0
AA 0 1 8 0
AID 0 3 3 0
Malignant (44)
PTC 0 0 4 25
FVPC 0 1 5 4
FTC 0 0 1 2
MTC 0 0 0 2
histology revealed benign thyroid lesions (MNG, FA, and
autoimmune thyroid diseases (AID).
3.3. Accuracy of FNAB. To determine the accuracy of FNAB,
we analyzed only adequate samples (153 cases). The sen-
sitivity, speciﬁcity, and predictive values were determined
usingtwoapproaches:consideringsuspiciousFNABaseither
“negatives” or “positives” for malignancy.
When only malignant FNABs were considered as “pos-
itive” and suspicious FNABs were considered as “negative”,
there were 33 true positive, 11 false negative, 109 true nega-
tive, and 0 false positive cases. The sensitivity and speciﬁcity
were 75.0% and 100%, respectively. When malignant and
suspicious FNABs were considered as “positive”, there were
43truepositive,1falsenegative,69truenegative,and40false
positive cases. The sensitivity and speciﬁcity were 97.7% and
63.3%, respectively.
3.4. TPO Immunocytochemistry with MoAb47 on FNAB. In
the present study we assessed the utility of TPO immuno-
cytochemistry with MoAb47 in the diagnosis of pediatric
thyroid nodules. The preoperative MoAb47 immunostaining
was performed in 54 patients that consequently underwent
surgery. Histological examination showed the presence of
benign and malignant thyroid lesions in 32 and 22 cases,
respectively.Twentyfourof33patientswithbenignhistology
demonstrated high level of MoAb47 staining (more than
80% cells are MoAb47 positive), but all malignant lesions
showed low level of staining.
The results of standard cytology and MoAb47 immunos-
taining in function of histology are summarized in Figure 1.
In benign FNAB, MoAb47 immunostaining was positive in
19/20 cases, but negative in 1 case that was determined to
be an FVPC by histology. In patients with suspicious FNAB,
MoAb47 immunostaining was positive in 7 lesions with
benign histology (MNG and FA), but decreased in cancers
and in tumors with limited nuclear features of papillary
thyroid cancers. All malignant FNABs were characterized4 International Journal of Pediatric Endocrinology
Table 4: Diagnostic accuracy of standard cytology and MoAb47
immunostaining.
Standard cytology MoAb47
Sensitivity 95.4% 100%
Speciﬁcity 55.8% 75%
PPV 61.7% 73.3%
NPV 95% 100%
Benign 20
Suspicious 16
Malignant 18
Positive 19 MNG 11, FA 6, AID 2
Negative 1
Positive 5
Negative 11
Positive 0
Negative 18
FVPTC 1
MNG 4, FA 1
MNG 1, FA 2, AA 5,
FVPTC 2, PTC 1
PTC 14, FVPTC 3, FTC 1
Cytology MoAb47 Histology
Figure 1: Comparison of standard cytological diagnoses to
MoAb47 and histology.
by decreased level of MoAb47 immunostaining. Statistical
analysis of results with standard cytology and MoAb47
immunostaining is presented in Table 4.
4. Discussion
Fine-needle aspiration biopsy of the thyroid gland is mini-
mally invasive and highly accurate in the diagnosis of thyroid
nodules in adults and in the pediatric population [8, 16].
The usefulness of this technique has been documented in
numerous studies comparing thousands of FNAB with ﬁnal
histologyintheadultpopulation[10,17,18].However,there
is limited data on FNAB followed by surgery in pediatric
thyroid nodules.
This retrospective study represents the largest number
of FNAB samples in pediatric patients with histological
conﬁrmation and the ﬁrst study to report on the use of
MoAb47 as a diagnostic tool for pediatric FNAB.
The cohort of patients in our study were evaluated by
FNAB after a thyroid nodule was discovered on routine
physical exam and represents less than 0.5% of all patients
that underwent FNAB in the Center for Endocrine Surgery
in Kiev. While the geographic location suggests exposure to
ionizingradiationfromtheChernobylaccident,92.5%ofthe
patients in this study were born after this event, reducing the
likelihood of this eﬀect.
Results from the demographic data demonstrated a
marked increase in the prevalence of thyroid nodules in
children of pubertal age, with a disproportionate increase in
female patients. These data suggest that hormones associated
with puberty may promote the development of thyroid
nodules in adolescence. Previous studies have demonstrated
an association of estrogen receptor expression and serum
IGF-1 level with development of thyroid nodules [19–23].
However, additional studies are needed to determine if a
causal relationship exists.
The distribution of cytological diagnoses in the present
studywassimilartopreviouslyreportedpediatricFNABdata
[8, 16]. More than 50% of patients that were operated at the
Center for Endocrine Surgery had suspicious or malignant
FNAB, therefore conﬁrming the role of FNAB as a screening
method for selection of patients for surgery.
Comparison of FNAB results to ﬁnal histology showed
that benign and malignant FNABs have a high negative and
positive predictive value, respectively. However, suspicious
FNAB diagnoses were the major source of false-negative as
well as false-positive results. These data are consistent with
previously reported ﬁndings [3–7, 10, 18, 24] and showed
that suspicious FNABs are a major diagnostic pitfall in
making therapeutic decisions for pediatric patients.
Histological analysis of operated suspicious FNAB in
our series revealed that this group includes malignant
tumors (20%), tumors with uncertain malignant potential
or atypical adenomas (16%) and purely benign lesions
(64%). In other reported series, the rate of malignancy in
thyroidectomyspecimens of patients with aninitial cytologic
diagnosis of “suspicious FNAB” varies from 15% to 38% in
adults and from 10% to 35% in children [3–7, 10, 18, 24].
These ﬁndings reﬂect the diagnostic dilemma surround-
ing follicular thyroid lesions. It was demonstrated that FNAB
followed by standard staining cannot distinguish benign
from malignant follicular tumors such as FTCs and follicular
variant of PTC [25, 26].
Malignancy markers have shown promise as an adjunct
in establishing the diagnosis of cancer on FNAB. Thyroid
peroxidase immunostaining using MoAb47 is one of the
ﬁrst malignancy markers reported to have potential utility to
distinguish benign and malignant lesions on thyroid FNAB
samples [27]. MoAb47 has been shown to have a sensitivity
of 98% and speciﬁcity of 80% [28, 29] in the diagnosis of
thyroid nodules in adults.
In this study we examined the usefulness of MoAb47
immunostaining in a series of 54 pediatric FNABs. Loss
of immunoreactivity with MoAb47 was observed in all
malignant thyroid lesions and in tumors with uncertain
malignant potential. In contrast, a high level of staining with
MoAb47 was detected on FNAB from most histologically
benign thyroid lesions. MoAb47 immunostaining in suspi-
cious FNAB was helpful in identifying histologically benign
thyroid lesions. These results are consistent with previously
reported data demonstrating that MoAb47 immunostaining
enhances sensitivity and speciﬁcity of standard cytology.International Journal of Pediatric Endocrinology 5
In summary, among children and adolescents who
underwent FNAB, thyroid cytology had a sensitivity and
speciﬁcity similar to those reported in the adult population.
Most suspicious FNABs in pediatric nodules were benign on
ﬁnal histology. Our data suggests that MoAb47 immunos-
taining may be a useful adjunct in establishing cytological
diagnoses, especially in cases of suspicious FNAB.
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